Clinical Trial Update: Long-term Efficacy and Safety of Lamazym for the Treatment of Patients With Alpha-Mannosidosis [Phase 2]

View source ↗

Summary

This update summarizes the long-term efficacy and safety results from a Phase 2 study of Lamazym in patients with Alpha-Mannosidosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-mannosidosis

Drugs mentioned

• Lamazym

Snippet

Sponsor: Zymenex A/S | Conditions: Alpha-Mannosidosis | Phase 2 | Status: COMPLETED